StockStory ชี้ Veralto, Toll Brothers และ Labcorp เป็นหุ้นขนาดกลางที่ควรหลีกเลี่ยง

Labcorp experienced a 1.6% annual sales decline over five years and an 11.1% annual drop in earnings per share, with organic revenue underperforming

Toll Brothers saw its backlog decline by an average of 9.1% over two years and expects a 2.9% sales drop

Veralto posted annual revenue growth of just 4.4% over four years and faces shaky demand with projected sales growth of 6.5%